Scholarly Index
Bradley E. Chipps
Capital Allergy and Respiratory Disease Center; 9,353 total citations; 442 total publications; best world rank #54
Capital Allergy and Respiratory Disease Center
9,353Total citations
442Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Asthma and respiratory diseases | Lifetime | 407 | US 151 | 99.00 |
| Respiratory and Cough-Related Research | Lifetime | 164 | US 60 | 98.95 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 175 | US 69 | 98.51 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 472 | US 162 | 98.37 |
| Allergic Rhinitis and Sensitization | Lifetime | 431 | US 125 | 98.28 |
| Pediatric health and respiratory diseases | Lifetime | 460 | US 167 | 97.06 |
| Pharmaceutical studies and practices | Lifetime | 561 | US 258 | 96.27 |
| Asthma and respiratory diseases | 2021-2025 | 181 | US 49 | 98.27 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 54 | US 13 | 96.74 |
| Respiratory and Cough-Related Research | 2021-2025 | 68 | US 16 | 97.62 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 232 | US 64 | 96.85 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 862 | US 189 | 87.43 |
| Pharmaceutical studies and practices | 2021-2025 | 446 | US 149 | 83.58 |
| Eosinophilic Esophagitis | 2021-2025 | 900 | US 285 | 83.50 |